- Home
- DNTH vs MSBI Comparison
DNTH vs MSBI Comparison
Compare DNTH & MSBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- MSBI
- Stock Information
- Founded
- DNTH 2015
- MSBI 1881
- Country
- DNTH United States
- MSBI United States
- Employees
- DNTH N/A
- MSBI N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- MSBI Major Banks
- Sector
- DNTH Health Care
- MSBI Finance
- Exchange
- DNTH Nasdaq
- MSBI Nasdaq
- Market Cap
- DNTH 606.2M
- MSBI 372.6M
- IPO Year
- DNTH N/A
- MSBI 2016
- Fundamental
- Price
- DNTH $19.94
- MSBI $18.74
- Analyst Decision
- DNTH Strong Buy
- MSBI Hold
- Analyst Count
- DNTH 8
- MSBI 3
- Target Price
- DNTH $53.00
- MSBI $20.67
- AVG Volume (30 Days)
- DNTH 374.8K
- MSBI 139.2K
- Earning Date
- DNTH 08-07-2025
- MSBI 07-24-2025
- Dividend Yield
- DNTH N/A
- MSBI 6.56%
- EPS Growth
- DNTH N/A
- MSBI N/A
- EPS
- DNTH N/A
- MSBI N/A
- Revenue
- DNTH $6,524,000.00
- MSBI $174,721,000.00
- Revenue This Year
- DNTH N/A
- MSBI $21.56
- Revenue Next Year
- DNTH N/A
- MSBI $1.51
- P/E Ratio
- DNTH N/A
- MSBI N/A
- Revenue Growth
- DNTH 102.36
- MSBI N/A
- 52 Week Low
- DNTH $13.37
- MSBI $14.79
- 52 Week High
- DNTH $32.27
- MSBI $28.08
- Technical
- Relative Strength Index (RSI)
- DNTH 57.13
- MSBI 63.55
- Support Level
- DNTH $17.88
- MSBI $18.43
- Resistance Level
- DNTH $23.37
- MSBI $18.98
- Average True Range (ATR)
- DNTH 1.35
- MSBI 0.52
- MACD
- DNTH 0.31
- MSBI 0.17
- Stochastic Oscillator
- DNTH 48.96
- MSBI 85.72
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About MSBI Midland States Bancorp Inc.
Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.